These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23786800)

  • 1. Perceptions of drug users regarding hepatitis C screening and care: a qualitative study.
    Jordan AE; Masson CL; Mateu-Gelabert P; McKnight C; Pepper N; Bouche K; Guzman L; Kletter E; Seewald RM; Des-Jarlais DC; Sorensen JL; Perlman DC
    Harm Reduct J; 2013 Jun; 10():10. PubMed ID: 23786800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Racial Disparities in HCV Infection and Care Outcomes in a Southern Urban Population.
    McGonigle K; Carley T; Hoff C
    J Racial Ethn Health Disparities; 2018 Oct; 5(5):1052-1058. PubMed ID: 29288470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and facilitators of hepatitis C screening among people who inject drugs: a multi-city, mixed-methods study.
    Barocas JA; Brennan MB; Hull SJ; Stokes S; Fangman JJ; Westergaard RP
    Harm Reduct J; 2014 Jan; 11():1. PubMed ID: 24422784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a brief educational program on knowledge and willingness to accept treatment among patients with hepatitis C at inner-city hospitals.
    Gupta K; Romney D; Briggs M; Benker K
    J Community Health; 2007 Aug; 32(4):221-30. PubMed ID: 17696047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection.
    Dalgard O; Egeland A; Skaug K; Vilimas K; Steen T
    Hepatology; 2004 Jan; 39(1):74-80. PubMed ID: 14752825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associating conditional cash transfer to universal access to treatment could be the solution to the HCV epidemic among drug users (DUs).
    Chossegros P; Di Nino F
    Harm Reduct J; 2018 Dec; 15(1):63. PubMed ID: 30541570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and Facilitators for Clinical Care Engagement Among HIV-Positive African American and Latino Men Who Have Sex with Men.
    Carey JW; Carnes N; Schoua-Glusberg A; Kenward K; Gelaude D; Denson D; Gall E; Randall LA; Frew PM
    AIDS Patient Care STDS; 2018 May; 32(5):191-201. PubMed ID: 29668307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Offers of hepatitis C care do not lead to treatment.
    Schackman BR; Teixeira PA; Beeder AB
    J Urban Health; 2007 May; 84(3):455-8. PubMed ID: 17394085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaps in the hepatitis C continuum of care among sex workers in Vancouver, British Columbia: Implications for voluntary hepatitis C virus testing, treatment and care.
    Socías ME; Shannon K; Montaner JS; Guillemi S; Dobrer S; Nguyen P; Goldenberg S; Deering K
    Can J Gastroenterol Hepatol; 2015; 29(8):411-6. PubMed ID: 26492129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV treatment access among Latinxs who inject drugs: qualitative findings from Boston, Massachusetts, 2016.
    Mittal A; Kosinski KC; Stopka TJ
    Harm Reduct J; 2019 Jul; 16(1):44. PubMed ID: 31288811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C in Intravenous Drug Users: Study of Obstacles and Facilitators to Access to Health Care and Services].
    Foley V; Petit GI; Giraud MJ; Boisvert K; Rietmann MH; Brousselle A
    Sante Publique; 2016; 28(3):363-74. PubMed ID: 27531434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. African-American and Hispanic perceptions of HIV vaccine clinical research: a qualitative study.
    Toledo L; McLellan-Lemal E; Arreola S; Campbell C; Sutton M
    Am J Health Promot; 2014; 29(2):e82-90. PubMed ID: 24432823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US South.
    Sherbuk JE; Tabackman A; McManus KA; Kemp Knick T; Schexnayder J; Flickinger TE; Dillingham R
    Harm Reduct J; 2020 Sep; 17(1):64. PubMed ID: 32948189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family medicine-directed hepatitis C care and barriers to treatment: a mixed-methods study.
    von Aesch Z; Craig-Neil A; Shah H; Antoniou T; Meaney C; Pinto AD
    CMAJ Open; 2021; 9(1):E201-E207. PubMed ID: 33688028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awareness of hepatitis C infection among women with and at risk for HIV.
    Cohen MH; Grey D; Cook JA; Anastos K; Seaberg E; Augenbraun M; Burian P; Peters M; Young M; French A
    J Gen Intern Med; 2007 Dec; 22(12):1689-94. PubMed ID: 17924170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project.
    Lindenburg CE; Lambers FA; Urbanus AT; Schinkel J; Jansen PL; Krol A; Casteelen G; van Santen G; van den Berg CH; Coutinho RA; Prins M; Weegink CJ
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):23-31. PubMed ID: 21042221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care provider perceptions and experiences of implementing hepatitis C virus birth cohort testing: a qualitative formative evaluation.
    Yakovchenko V; Bolton RE; Drainoni ML; Gifford AL
    BMC Health Serv Res; 2019 Apr; 19(1):236. PubMed ID: 31014322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Yield Birth-Cohort Hepatitis C Virus Screening and Linkage to Care Among Underserved African Americans, Atlanta, Georgia, 2012-2013.
    Miller LS; Rollin F; Fluker SA; Lundberg KL; Park B; Quairoli K; Niyibizi NK; Spaulding AC
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):84-90. PubMed ID: 27168666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration.
    Swan D; Long J; Carr O; Flanagan J; Irish H; Keating S; Keaveney M; Lambert J; McCormick PA; McKiernan S; Moloney J; Perry N; Cullen W
    AIDS Patient Care STDS; 2010 Dec; 24(12):753-62. PubMed ID: 21138381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral treatment for chronic hepatitis C in illicit drug users: a systematic review.
    Zanini B; Lanzini A
    Antivir Ther; 2009; 14(4):467-79. PubMed ID: 19578232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.